On November 20, 2025, Veeva Systems Inc. (NYSE: VEEV), a prominent player in the industry cloud solutions sector for the global life sciences market, announced its financial results for the third quarter ended October 31, 2025. The company showcased robust growth across its revenue streams, reaffirming its commitment to innovation and operational excellence.

In a statement, CEO Peter Gassner emphasized the transformative potential of Veeva AI, underscoring its role in enhancing productivity and customer focus within the life sciences sector. "Veeva AI is advancing rapidly, and our early adopter projects are demonstrating the clear value in deep, specialized AI agents running in Veeva applications," Gassner noted.

2. Fiscal 2026 Third Quarter Financial Highlights

The financial results for Veeva Systems for the third quarter are as follows:

Total Revenues: Veeva reported total revenues of $811.2 million for the quarter, reflecting a 16% increase from $699.2 million in the same period last year.

Subscription Services Revenues: Subscription services revenues reached $682.5 million, a 17% increase compared to $580.9 million a year ago.

Operating Income: The company’s operating income was reported at $240.9 million, a significant 33% increase from $181.4 million in the prior year.

Non-GAAP Operating Income: Adjusted figures indicate a non-GAAP operating income of $364.9 million, up from $304.0 million year-over-year, marking a 20% increase.

Net Income: Veeva’s net income for the quarter was $236.2 million, representing a 27% rise from $185.8 million in the previous year.

Non-GAAP Net Income: The non-GAAP net income was reported at $345.1 million, an increase of 20% from $288.3 million year-over-year.

Earnings per Share: Fully diluted net income per share stood at $1.40 compared to $1.13 in the prior year, while non-GAAP fully diluted net income per share was $2.04, up from $1.75.

CFO Brian Van Wagener commented on the positive results, stating, "Our third quarter results and increased full-year guidance demonstrate the broad-based strength we see across the business. We are executing well against the large opportunity ahead and are on track toward our 2030 $6 billion revenue run-rate goal."

3. Recent Highlights and Strategic Developments

Advancements in Veeva AI

Veeva AI has made significant strides, with the development of industry-specific AI agents designed to enhance productivity in the life sciences sector. The company is on track to launch its first AI agents for Customer Relationship Management (CRM) and commercial content in December, with further developments planned for Research & Development (R&D), quality, and additional commercial agents throughout 2026.

Success in CRM and Customer Expansion

The Veeva Vault CRM platform experienced substantial growth, adding 23 new customers in the quarter, bringing the total to 115. Notably, a significant rollout occurred with a top 20 biopharma company in Japan, highlighting the platform’s capability to manage complex global operations.

Growth in Development Cloud Opportunities

Veeva continues to expand its Development Cloud, which represents a major opportunity in the life sciences sector. Three top 20 biopharma companies selected Veeva Development Cloud applications as their enterprise standard in this quarter, including applications for Study Startup, Study Training, and Safety. This growth is pivotal as the industry seeks to modernize pharmacovigilance practices.

4. Financial Outlook

Looking ahead, Veeva provided guidance for the upcoming fiscal fourth quarter ending January 31, 2026:

Total Revenues: Expected to be between $807 million and $810 million.

Non-GAAP Operating Income: Projected at approximately $350 million.

Non-GAAP Fully Diluted Net Income per Share: Anticipated to be around $1.92.

For the full fiscal year ending January 31, 2026, Veeva revised its guidance to forecast total revenues between $3,166 million and $3,169 million, with non-GAAP operating income expected to be about $1,417 million and non-GAAP fully diluted net income per share projected at approximately $7.93.

5. Conclusion

Veeva Systems Inc. continues to demonstrate strong financial performance while leading innovation in the life sciences industry through its AI initiatives and cloud solutions. With a positive outlook for the upcoming quarters, Veeva is well-positioned to capitalize on the growing demand for its services and technologies. Investors and analysts will be keen to observe the company's trajectory as it progresses toward its ambitious revenue goals.

A conference call to discuss these results further is scheduled for 2:00 p.m. PT on November 20, 2025, providing an opportunity for stakeholders to engage with Veeva's leadership team.

Original press release